Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PAROXETINE | 30MG | TABLET | Resolved | 2018-06-04 | 2018-07-25 | 51194 |
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2018-11-30 | 2018-12-20 | 68236 |
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2020-04-13 | 2020-04-27 | 111936 |
| APO-PAROXETINE | 30MG | TABLET | Resolved | 2020-04-13 | 2020-04-27 | 111943 |
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2021-04-16 | 2021-04-26 | 137592 |
| APO-PAROXETINE | 30MG | TABLET | Resolved | 2021-10-22 | 2021-10-29 | 147821 |
| APO-PAROXETINE | 10MG | TABLET | Resolved | 2023-09-22 | 2023-10-06 | 205006 |
| APO-PAROXETINE | 30MG | TABLET | Resolved | 2023-09-22 | 2023-10-06 | 205018 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2018-08-09 | 2018-11-19 | 57802 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2018-10-11 | 2018-11-22 | 63800 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2019-05-01 | 2019-06-08 | 82907 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2020-07-08 | 2020-09-04 | 119765 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2020-07-23 | 2020-09-04 | 120985 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2021-09-03 | 2021-09-27 | 145153 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2021-09-24 | 2021-09-27 | 146160 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2021-10-29 | 2021-11-15 | 148539 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-03-04 | 2022-03-24 | 156036 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2022-05-13 | 2022-06-06 | 160604 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-05-27 | 2022-08-11 | 161451 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2022-07-29 | 2022-10-21 | 165730 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
| APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 61033 |
| APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
| APO-SULIN TAB 200MG | 200MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1172 |
| APO-TADALAFIL | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-02-13 | 61045 |
| APO-TAMOX TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-09-12 | 61050 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71345 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |
| APO-TERAZOSIN | 5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4749 |
| APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |